2009
Asymmetric Dimethylarginine in the Maternal and Fetal Circulation in Preeclampsia
Abstract: Preeclampsia is a leading cause of intrauterine growth restriction and preterm birth. Endothelial dysfunction is the common final pathway leading to clinical signs of preeclampsia including hypertension and proteinuria. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NOS and induces endothelial dysfunction by reversibly inhibiting NO production from L-arginine. The purpose of this study was to investigate maternal and fetal concentrations of ADMA, L-arginine, and symmetric dimethylarginine (SD…
Search citation statements
Paper Sections
Select...
45
10
8
2
Citation Types
4
44
0
0
Year Published
Range
2010
2026
Publication Types
Select...
60
2
Relationship
0
62
Authors
Journals
Cited by 62 publications
(48 citation statements)
References 41 publications
4
44
0
0
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…We found progressive increases in the ADMA, blood pressure parameters, and heart rate throughout gestation in the overall high-risk cohort, which is consistent with endothelial dysfunction and accumulating cardiovascular strain. These results are consistent with earlier studies showing that elevated ADMA levels during pregnancy are a sign of endothelial stress [ 20 , 22 ]. On the other hand, the cfPWV stayed constant during pregnancy, indicating a preserved arterial compliance, which could be the result of compensatory mechanisms, like an increased cardiac output or systemic vasodilation [ 25 , 26 ].…”
Section: Discussion
supporting
confidence: 93%